Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL3612510 | 0.98 | CYP2D6 (0.38) | CYP2D6DGAT1CA2CA12CA14 | |
| SCHEMBL7223189 | 0.89 | CA2 (0.40) | CYP2D6DGAT1CA2CA12CA14 | |
| SCHEMBL3940721 | 0.89 | ALDH1A1 (0.39) | CYP2D6DGAT1CA2CA12CA14 | |
| SCHEMBL12128758 | 0.84 | GAA (0.50) | ALDH1A1GAAL3MBTL1 | |
| SCHEMBL8641614 | 0.83 | CYP2D6 (0.31) | CYP2D6DGAT1GAA | |
| SCHEMBL4838871 | 0.83 | TET2 (0.42) | CYP2D6DGAT1CA2CA12CA14 | |
| SCHEMBL28320509 | 0.83 | GAA (0.36) | CYP2D6DGAT1CA2CA12CA14 | |
| SCHEMBL7085941 | 0.83 | ALOX15 (0.39) | CYP2D6DGAT1CA2CA12CA14 | |
| SCHEMBL22615873 | 0.81 | CYP2D6 (0.40) | CYP2D6CA2CA1CA7 | |
| SCHEMBL23588117 | 0.81 | MAOA (0.38) | CYP2D6DGAT1CA2TDP1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114316250-B | Polyether secondary amine ester resin and preparation method thereof | 深圳飞扬骏研新材料股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-115895558-A | Polyurea adhesive and preparation method and application thereof | 深圳飞扬骏研新材料股份有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-114315621-A | Aliphatic secondary amino ester resin and preparation method thereof | 深圳飞扬骏研新材料股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114316250-A | Polyether family secondary amine ester resin and preparation method thereof | 深圳飞扬骏研新材料股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-20020164548-A1 | Wet etch compatible deep UV photoresist compositions | ARCH SPECIALTY CHEMICALS, INC. | 2002-11-07 | — | — | US | claimed |
| US-5883152-A | HARD CONTACT LENS CONSISTING OF A COPOLYMER OF CARBOXYLIC ACID ESTER MONOMER, TRIS(TRIMETHYLSILOXY)SILYLPROPYL(METH)ACRYLATE, AND COPOLYMERIZABLE MONOMER | NIPPON OIL AND FATS CO., LTD. (JP) | 1999-03-16 | — | — | US | claimed |
| JP-3292332-A | — | — | None | — | — | JP | disclosed |
| US-20250205188-A1 | TREATMENT OR PREVENTION OF RESPIRATORY DISEASES CHARACTERISED BY, OR INVOLVING, LUNG FIBROSIS | IMPERIAL COLLEGE INNOVATIONS LTD (GB) | 2025-06-26 | — | — | US | disclosed |
| CN-114315621-B | Aliphatic secondary amino ester resin and preparation method thereof | 深圳飞扬骏研新材料股份有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-114316250-B | Polyether secondary amine ester resin and preparation method thereof | 深圳飞扬骏研新材料股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| WO-2023175336-A1 | ITACONATE ANALOGUES FOR TREATMENT OR PREVENTION OF RESPIRATORY DISEASES CHARACTERISED BY, OR INVOLVING, LUNG FIBROSIS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-09-21 | — | — | WO | disclosed |
| WO-2023175336-A1 | ITACONATE ANALOGUES FOR TREATMENT OR PREVENTION OF RESPIRATORY DISEASES CHARACTERISED BY, OR INVOLVING, LUNG FIBROSIS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-09-21 | — | — | WO | disclosed |
| CN-113462443-B | Diesel antiwear agent composition, preparation method thereof and diesel oil composition | 中国石油化工股份有限公司 | 2023-07-14 | — | — | CN | disclosed |
| EP-0425831-A2 | Contact lens | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1991-05-08 | — | — | EP | disclosed |
| US-4975471-A | Photo-curable epoxy resin type composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1990-12-04 | — | — | US | disclosed |
| US-4743667-A | ACRYLATED SILOXXANES, OXYGEN PERMEABLE | NIPPON CONTACT LENS, INC. (JP) | 1988-05-10 | — | — | US | disclosed |
| EP-0123842-B1 | PHOTO-CURABLE EPOXY RESIN TYPE COMPOSITION | KABUSHIKI KAISHA TOSHIBA (JP) | 1987-08-19 | — | — | EP | disclosed |
| EP-0195846-A2 | Photo-curable epoxy resin type composition and curing process | KABUSHIKI KAISHA TOSHIBA (JP) | 1986-10-01 | — | — | EP | disclosed |
| EP-0123842-A1 | Photo-curable epoxy resin type composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1984-11-07 | — | — | EP | disclosed |
| EP-0114258-A1 | Resin encapsulation type photo-semiconductor devices | KABUSHIKI KAISHA TOSHIBA (JP) | 1984-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250205188-A1 | TREATMENT OR PREVENTION OF RESPIRATORY DISEASES CHARACTERISED BY, OR INVOLVING, LUNG FIBROSIS | SDHA, SDHB, FH | CYP2D6 1184/4885DGAT1 832/4885CA2 494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.